48.73 -0.84 (-1.70%)
VRX
| Trade VRX now with |
|
Stock Details
Last Trade:48.73 Change:-0.84 (-1.70%) Prev Close:49.57 Open: 49.32 Days Range:48.12 – 49.54 52 Week Range: 32.05 - 57.24 Volume:967401 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 4:31pm
AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board
AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced the appointment of Rajiv De Silva and Gino Santini to its board of directors, effective immediately. Mr. De Silva is currently president of Valeant Pharmaceuticals International (NYSE: VRX) and... Read More
Recent Alert on 02/01/12 at 8:37am
Valeant Pharma (VRX) Acquires Probiotica Laboratorios in R$150M Deal
Valeant Pharma (VRX) Acquires Probiotica Laboratorios in R$150M Deal
Recent Alert on 01/30/12 at 10:34am
Notable Mergers and Acquisitions of the Day 1/30: [(ABB)/(TNB) (PBY) (VRX)/(ISTA)]
Notable Mergers and Acquisitions of the Day 1/30: [(ABB)/(TNB) (PBY) (VRX)/(ISTA)]
View AllRecent Press Releases
Press Release on 02/08/12 at 8:00am
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
Press Release on 02/08/12 at 8:00am
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
Press Release on 02/06/12 at 8:00am
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Press Release on 02/06/12 at 8:00am
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
View AllRecent SEC Filings
No Recent SEC Filings Available